Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sisu Pharma Inc. is addressing 1 pending office action. This action is assigned to 1 distinct examiner, NOTTINGHAM, KYLE GREGORY. NOTTINGHAM, KYLE GREGORY is the busiest examiner for the portfolio, overseeing the 1 pending office action.
Prosecution is currently concentrated in this 1 matter, allowing for a dedicated strategy for the 1 pending office action. Practitioners must address the specific concerns raised by the 1 distinct examiner to advance the application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18662751 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | NOTTINGHAM, KYLE GREGORY | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18662751 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | NOTTINGHAM, KYLE GREGORY | — | §102DP | Non-Final OA | — | Pending | May 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial